摘要:
This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating and preventing atherosclerosis and atherosclerotic disease events.
摘要:
This invention provides cholesterol absorption inhibitors of Formula I:I and the pharmaceutically acceptable salts thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating and preventing atherosclerosis and atherosclerotic disease events.
摘要:
This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating and preventing atherosclerosis and atherosclerotic disease events.
摘要:
The present invention is directed to certain phenyl pyrrolidine ether compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, depression, and anxiety.
摘要:
The present invention is concerned with compounds of the general Formula I: and pharmaceutically acceptable salts thereof, which are useful as melanin concentrating hormone receptor antagonists, particularly MCH-1R antagonists. As such, compounds of the present invention are useful for the treatment or prevention of obesity or eating disorders associated with excessive food intake and complications thereof, osteoarthritis, certain cancers, AIDS wasting, cachexia, frailty (particularly in elderly), mental disorders stress, cognitive disorders, sexual function, reproductive function, kidney function, locomotor disorders, attention deficit disorder (ADD), substance abuse disorders and dyskinesias, Huntington's disease, epilepsy, memory function, and spinal muscular atrophy. Compounds of formula I may therefore be used in the treatment of these conditions, and in the manufacture of a medicament useful in treating these conditions. Pharmaceutical formulations comprising one of the compounds of formula (I) as an active ingredient are disclosed, as are processes for preparing these compounds.
摘要:
An office chair foot base providing to support an office chair has a top end disposed towards the office chair, and a bottom end disposed opposite to the top end towards the ground. The office chair foot base comprises a main boy and a plurality of legs. The main boy includes an interior wall formed circularly and a connecting portion connecting to the interior wall at the bottom end. The plurality of legs formed radially extending opposite to the interior wall to a radial extent. Each of the plurality of legs includes a joining portion formed at the bottom end. The joining portion connects with the connecting portion.
摘要:
A chair includes a supporting structure, a seat moveably mounted on the supporting structure and being moveable with respect to the supporting structure in a vertical direction, and a backrest including a first frame pivotally connected to the seat and a second frame separate from and pivotally mounted on the first frame so as to connect to the seat. Further, a first control device is mounted and concealed between the first and second frames in order to prevent the user from inadvertently colliding with it. The first control device is adjusted for various relative pivotal positions of first and second frames.
摘要:
Polycrystalline materials are prepared by electrodeposition of a precursor material that is subsequently heat-treated to induce at least a threefold increase in the grain size of the material to yield a relatively high fraction of ‘special’ low Σ grain boundaries and a randomized crystallographic texture. The precursor metallic material has sufficient purity and a fine-grained microstructure (e.g., an average grain size of 4 nm to 5 μm). The resulting metallic material is suited to the fabrication of articles requiring high mechanical or physical isotropy and/or resistance to grain boundary-mediated deformation or degradation mechanisms.
摘要:
A rack and container assembly and the associated method of holding the containers in the rack. The rack has frame elements that define at least one slot of a first width. The frame elements are rounded in cross-section having a first radius of curvature. Each of the containers has an exterior surface of a second width that is greater than the width of the slots in the rack. An arcuate groove is formed in the exterior surface of each container. The arcuate grooves enable the containers to pass into the slots. Each arcuate groove has a cross-section with a second radius of curvature that is at least as large as the first radius of curvature of the frame elements that form the slot. When the containers are placed in the slots, the only area of the containers that physically contacts the rack is the shallow area of the arcuate groove.